Handelsbanken Fonder Ab Ascendis Pharma A/S Transaction History
Handelsbanken Fonder Ab
- $25.3 Billion
- Q3 2024
A detailed history of Handelsbanken Fonder Ab transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 17,667 shares of ASND stock, worth $2.37 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,667
Previous 13,467
31.19%
Holding current value
$2.37 Million
Previous $1.84 Million
43.6%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ASND
# of Institutions
244Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.3 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$689 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$670 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$592 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$562 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.49B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...